Betamethasone (Celestone Soluspan, Betaject) shortage status
Shortage anticipated
Source: Health Canada shortage reports · Updated Aug 18, 2026
A shortage of Betamethasone is anticipated but not yet confirmed. 1 product(s) have anticipated-shortage reports on file with Health Canada.
A corticosteroid used to reduce inflammation and treat a range of inflammatory conditions.
Products affected
0 / 2
Reports on file
14
Shortage history
Shortage history (red bands = periods in shortage).
Reports by product
The DIN is printed on your prescription label.
Anticipated
CELESTONE SOLUSPAN
3MG
3MG · SUSPENSION · ORGANON CANADA INC.
DIN 00028096 · Demand increase for the drug.
Resolved
CELESTONE SOLUSPAN
3MG
3MG · SUSPENSION · ORGANON CANADA INC.
DIN 00028096 · ended Feb 19, 2026 · Delay in shipping of the drug.
Resolved
CELESTONE SOLUSPAN
3MG
3MG · SUSPENSION · ORGANON CANADA INC.
DIN 00028096 · ended Apr 30, 2024 · Delay in shipping of the drug.
Resolved
CELESTONE SOLUSPAN
3MG
3MG · SUSPENSION · ORGANON CANADA INC.
DIN 00028096 · ended Feb 1, 2024 · Demand increase for the drug.
Resolved
CELESTONE SOLUSPAN
3MG
3MG · SUSPENSION · ORGANON CANADA INC.
DIN 00028096 · ended Nov 20, 2023 · Disruption of the manufacture of the drug.
Resolved
CELESTONE SOLUSPAN
3MG
3MG · SUSPENSION · ORGANON CANADA INC.
DIN 00028096 · ended Nov 15, 2023 · Disruption of the manufacture of the drug.
Resolved
CELESTONE SOLUSPAN
3MG
3MG · SUSPENSION · ORGANON CANADA INC.
DIN 00028096 · ended Aug 25, 2021 · Delay in shipping of the drug.
Resolved
CELESTONE SOLUSPAN
3MG
3MG · SUSPENSION · MERCK CANADA INC
DIN 00028096 · ended May 14, 2021 · Delay in shipping of the drug.
Resolved
CELESTONE SOLUSPAN
3MG
3MG · SUSPENSION · MERCK CANADA INC
DIN 00028096 · ended Nov 19, 2019 · Delay in shipping of the drug.
Resolved
CELESTONE SOLUSPAN
3MG
3MG · SUSPENSION · MERCK CANADA INC
DIN 00028096 · ended Nov 8, 2019 · Delay in shipping of the drug.
Resolved
CELESTONE SOLUSPAN
3MG
3MG · SUSPENSION · MERCK CANADA INC
DIN 00028096 · ended Nov 7, 2019 · Delay in shipping of the drug.
Discontinued
BETAJECT
SANDOZ CANADA INCORPORATED
DIN 02237835
Showing 12 of 14 reports. All reports are on file with Health Canada.
What's happening
A manufacturer has told Health Canada it expects supply of Betamethasone to fall short of demand. Anticipated shortages sometimes resolve without patients noticing; this page updates as soon as the status changes.
Betamethasone is classified under “CORTICOSTEROIDS FOR SYSTEMIC USE, PLAIN” (ATC H02AB).
Recent changes
Aug 14, 2026
New report filed
Common questions
What is Betamethasone used for?
A corticosteroid used to reduce inflammation and treat a range of inflammatory conditions.
When will Betamethasone be back in stock in Canada?
Manufacturers have not provided a reliable end date. This page updates automatically as soon as an estimate is filed.
Why is Betamethasone in shortage?
See the reports above; manufacturers must state a reason (most commonly manufacturing disruption or a surge in demand) when filing with Health Canada.
What can my pharmacist do about it?
Often quite a lot: substitute an equivalent product from an unaffected manufacturer, adjust quantities, or in most provinces adapt or renew prescriptions on the spot. Call your pharmacy before visiting, and call 811 for free health advice.
Email alerts
Get an email when this drug's status changes. Double opt-in, one-click unsubscribe.
Drugs in the same therapeutic class, best-supplied first. These are not automatic substitutes: only your pharmacist or prescriber can judge whether a switch makes sense for you.
Data reflects reports manufacturers are legally required to file with Health Canada, republished with per-drug aggregation by rxstat. Estimated end dates are supplied by manufacturers and frequently change. This page describes drug supply only and is not medical advice; never stop or switch a medication without speaking to your pharmacist or prescriber.